The biotech drug developer posted revenue of $874,900 in the period. Its adjusted revenue was $875,000. Salarius shares have fallen 33% since the ...
News
- Salarius: 3Q Earnings Snapshot
- Neuroprotection Drugs Market is Expected to Reach US$ 33481.7 Million by 2027, Growing at an ...
However, recent biotechnology advancements have the ability at predicting the ... Astrocyte Pharmaceuticals partnered with The University of Texas Health Science Center at San Antonio (DBA UT Health San Antonio), and the labs ...
- Fortress Biotech: 3Q Earnings Snapshot
NEW YORK (AP) _ Fortress Biotech Inc. (FBIO) on Tuesday reported a loss of $12.8 million in its third quarter. On a per-share basis, the New ...
- Leader of food security nonprofits to head World Food Prize
... some including the Iowa-based Occupy World Food Prize organization, which has accused corporate sponsors of being biotech, seed-and-chemical ...
- BriaCell to Present Clinical Findings at the 2019 San Antonio Breast Cancer Symposium ...
BriaCell to Present Clinical Findings at the 2019 San Antonio Breast Cancer ... BriaCell is an immuno-oncology focused biotechnology company ...